|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?|
|Myung Ji Goh, Dong Hyun Sinn|
|Clin Mol Hepatol. 2022;28(3):380-395. Published online 2022 January 13 DOI: https://doi.org/10.3350/cmh.2021.0366|
Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
Aspirin: Does it Have a Role for Chemoprevention of Hepatocellular Carcinoma?
Statins and metformin for chemoprevention of hepatocellular carcinoma
Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma – ready for their use? Authors' reply
Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma—ready for their use?
Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis
Letter to the editor: Aspirin use and the risk of hepatocellular carcinoma
The risk of hepatocellular carcinoma and aspirin use
Hepatocellular carcinoma: Ablate and wait versus rapid transplantation
Potential for statins in the chemoprevention and management of hepatocellular carcinoma
|This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.|